Puma AIM VCT (PAIM) ORD GBP0.01

The Company’s target is to produce attractive investment returns from a portfolio of companies traded on the AIM market of the London Stock Exchange, or on AQSE Trading or the AQSE Growth market of the Aquis Stock Exchange (as well as, potentially, unquoted UK companies).

The Investment Manager is paid an annual investment management fee of 2.0 per cent plus VAT if applicable of the Net Asset Value. The fee is payable quarterly in arrears

The Company seeks to achieve an average dividend payment of 5p per Ordinary Share per annum although this may vary significantly from year to year. The Company expects to be in a position to make dividend payments from the realisation of its investments or, to a lesser extent, income received from its investments. The Company’s ability to pay dividends is not guaranteed and is subject to adequate distributable reserves, legislative requirements and the available cash reserves of the Company. No forecast or projection is expressed or implied.

Stuart Rollason

Stuart Rollason has been working with the AIM market since its inception in 1995. He began his career in the financial industry as a broker research analyst analysing AIM stocks. In 2000 he became a fund manager, being part of a team that launched an investment trust focused on AIM, including VCT qualifying companies, as well as private companies. He managed a smaller company open-ended trust and was part of a team that managed an investment trust and a VCT. In 2011, he began managing an AIM inheritance tax service. Stuart joined Puma Investments in 2021 to manage the Service. Before joining Puma Investments, he was a partner at Kestrel Partners LLP, where he led its AIM inheritance tax service for a decade. In that time the Kestrel Inheritance Tax Solution portfolio produced a strong performance, delivering a compound annual growth rate of 12.38% pa to 31 March 2021 (source: Puma Investments with numbers unaudited). Prior to Kestrel, Stuart was part of an investment team that managed the Active Capital Trust plc, The AIM VCT plc and AIM VCT 2 (which was renamed Bluehone AIM VCT 2 plc). The two VCTs were subsequently merged and Stuart was part of the investment management team that managed the merged VCTs as Bluehone AIM VCT 2 plc. Stuart also managed £230 million of UK smaller company pension assets at ISIS Asset Management. Stuart was formerly an Extel-rated Research Analyst in Medical Technology and Biotech at Beeson Gregory, Panmure Gordon and Nomura, and began his career as a medical doctor practising in the NHS, before moving into research at Oxford University.

Jonathan Di-StefanoChairman, Eliot Kaye, Lynn Drummond